Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -2.36%2.72B | ---- | -58.87%2.79B | ---- | -56.49%6.78B | ---- | 96.27%15.58B | ---- | 54.92%7.94B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 74.41%-68.75M | ---- | -12.00%-268.66M | ---- | -158.24%-239.87M | ---- | 26.85%-92.89M | ---- | -5.18%-126.98M |
| Attributable subsidiary (profit) loss | ---- | 29.69%-123.76M | ---- | 33.11%-176M | ---- | -0.55%-263.13M | ---- | -248.02%-261.7M | ---- | 48.34%-75.2M |
| Impairment and provisions: | ---- | 3.92%1.31B | ---- | -37.97%1.26B | ---- | 384.71%2.03B | ---- | 1,866.07%419.82M | ---- | -94.14%21.35M |
| -Impairment of property, plant and equipment (reversal) | ---- | -45.18%303.15M | ---- | --553.03M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | -86.68%-263.08M | ---- | -133.30%-140.93M | ---- | 29.53%423.14M | ---- | 4,223.44%326.68M | ---- | -95.83%7.56M |
| -Impairment of trade receivables (reversal) | ---- | -230.63%-152.02M | ---- | -240.37%-45.98M | ---- | -64.83%32.75M | ---- | 575.05%93.14M | ---- | -92.47%13.8M |
| -Other impairments and provisions | ---- | 58.87%1.42B | ---- | -43.24%896.19M | ---- | --1.58B | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | 138.58%76.16M | ---- | -153.34%-197.41M | ---- | 264.90%370.07M | ---- | -122.81%-224.42M | ---- | 2,184.91%983.72M |
| -Fair value of investment properties (increase) | ---- | -71.50%32.33M | ---- | -23.13%113.43M | ---- | 1,125.57%147.56M | ---- | -364.63%-14.39M | ---- | 186.81%5.44M |
| -Other fair value changes | ---- | 114.10%43.83M | ---- | -239.70%-310.84M | ---- | 205.94%222.51M | ---- | -121.47%-210.03M | ---- | 2,490.73%978.29M |
| Asset sale loss (gain): | ---- | 2,520.00%12.31M | ---- | -96.42%470K | ---- | 109.16%13.14M | ---- | -223.14%-143.46M | ---- | -151.56%-44.4M |
| -Available for sale investment sale loss (gain) | ---- | 83.57%-4.93M | ---- | 73.74%-30.01M | ---- | 2.41%-114.27M | ---- | -10.20%-117.09M | ---- | 25.25%-106.25M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -652.89%-224.18M | ---- | ---29.78M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -43.42%17.24M | ---- | -76.08%30.48M | ---- | -35.59%127.41M | ---- | 115.88%197.8M | ---- | -59.86%91.62M |
| Depreciation and amortization: | ---- | 0.25%1.99B | ---- | 5.20%1.99B | ---- | -2.84%1.89B | ---- | 15.17%1.95B | ---- | -12.39%1.69B |
| -Amortization of intangible assets | ---- | 0.00%6.48M | ---- | 0.00%6.48M | ---- | 0.00%6.48M | ---- | 0.00%6.48M | ---- | 63.64%6.48M |
| Financial expense | ---- | 2.31%1.15B | ---- | 122.99%1.12B | ---- | 83.05%504.27M | ---- | -39.74%275.48M | ---- | -39.21%457.18M |
| Special items | ---- | ---- | ---- | -1.03%124.01M | ---- | --125.3M | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 6.44%7.07B | ---- | -40.73%6.65B | ---- | -35.91%11.21B | ---- | 61.37%17.5B | ---- | 32.70%10.84B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -59.58%-269.1M | ---- | 46.90%-168.62M | ---- | 73.16%-317.56M | ---- | -1,103.81%-1.18B | ---- | -75.05%117.88M |
| Developing property (increase)decrease | ---- | 227.10%715.57M | ---- | -73.91%218.76M | ---- | 172.35%838.41M | ---- | -156.12%-1.16B | ---- | 185.45%2.06B |
| Accounts receivable (increase)decrease | ---- | -9,107.24%-1.05B | ---- | -100.27%-11.42M | ---- | 198.52%4.16B | ---- | -593.42%-4.22B | ---- | 153.68%854.82M |
| Accounts payable increase (decrease) | ---- | 75.53%-79.94M | ---- | -545.09%-326.71M | ---- | -102.86%-50.65M | ---- | 150.51%1.77B | ---- | 190.21%705.82M |
| Financial assets at fair value (increase)decrease | ---- | -61.73%233.34M | ---- | 494.97%609.7M | ---- | 90.42%-154.36M | ---- | -77.28%-1.61B | ---- | -2,977.72%-908.73M |
| Special items for working capital changes | ---- | 53.76%-367.93M | ---- | 66.94%-795.7M | ---- | -288.35%-2.41B | ---- | 149.27%1.28B | ---- | -187.34%-2.59B |
| Cash from business operations | ---- | 1.34%6.25B | ---- | -53.51%6.17B | ---- | 7.32%13.28B | ---- | 11.63%12.37B | ---- | 27.08%11.08B |
| Hong Kong profits tax paid | ---- | 114.62%927K | ---- | 97.65%-6.34M | ---- | -854.95%-270.12M | ---- | -12.46%-28.29M | ---- | 64.99%-25.15M |
| China income tax paid | ---- | 39.69%-462.64M | ---- | 67.89%-767.12M | ---- | 14.64%-2.39B | ---- | -74.60%-2.8B | ---- | -206.05%-1.6B |
| Other taxs | ---- | 64.24%-31.46M | ---- | -167.87%-87.96M | ---- | 25.56%-32.84M | ---- | -197.71%-44.11M | ---- | 105.41%45.15M |
| Special items of business | 290.78%605.97M | ---- | -129.32%-317.63M | ---- | -69.03%1.08B | ---- | -0.37%3.5B | ---- | 6.29%3.51B | ---- |
| Net cash from operations | 290.78%605.97M | 8.49%5.76B | -129.32%-317.63M | -49.83%5.31B | -69.03%1.08B | 11.42%10.58B | -0.37%3.5B | 0.00%9.5B | 6.29%3.51B | 30.30%9.5B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -70.38%77.91M | ---- | 4.49%263.03M | ---- | 130.48%251.73M | ---- | 34.36%109.22M | ---- | -32.66%81.29M |
| Dividend received - investment | ---- | -34.86%173.06M | ---- | 10.62%265.65M | ---- | 180.43%240.15M | ---- | -34.85%85.64M | ---- | -49.31%131.45M |
| Loan receivable (increase) decrease | ---- | -81.78%65.4M | ---- | 411.71%358.95M | ---- | 105.84%70.15M | ---- | -1,300.90%-1.2B | ---- | 121.18%100.1M |
| Sale of fixed assets | ---- | -75.84%82.18M | ---- | 214.07%340.12M | ---- | 66.02%108.3M | ---- | -94.17%65.23M | ---- | 267.00%1.12B |
| Purchase of fixed assets | ---- | -1.34%-4.07B | ---- | 20.30%-4.02B | ---- | -33.69%-5.04B | ---- | -133.05%-3.77B | ---- | 40.17%-1.62B |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -51.66%28.82M | ---- | --59.61M |
| Purchase of intangible assets | ---- | -29.15%-149.89M | ---- | 53.79%-116.06M | ---- | -72.60%-251.13M | ---- | -178.86%-145.5M | ---- | 43.77%-52.18M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -114.94%-43.16M | ---- | --288.94M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---2.8B | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | -58.88%101.76M | ---- | -60.95%247.46M | ---- | -33.56%633.66M | ---- | -86.57%953.76M | ---- | 97.29%7.1B |
| Cash on investment | ---- | 139.61%2.21B | ---- | -483.13%-5.58B | ---- | 169.63%1.46B | ---- | 52.97%-2.09B | ---- | -173.06%-4.45B |
| Other items in the investment business | -302.62%-3.57B | ---- | 82.94%-887.62M | ---- | -127.97%-5.2B | ---- | -3,376.97%-2.28B | ---- | -97.87%69.65M | ---- |
| Net cash from investment operations | -302.62%-3.57B | 81.65%-1.51B | 82.94%-887.62M | -54.58%-8.24B | -127.97%-5.2B | 11.33%-5.33B | -3,376.97%-2.28B | -317.48%-6.01B | -97.87%69.65M | 177.78%2.76B |
| Net cash before financing | -146.24%-2.97B | 245.01%4.25B | 70.75%-1.21B | -155.78%-2.93B | -439.07%-4.12B | 50.63%5.25B | -66.06%1.22B | -71.56%3.49B | -45.52%3.58B | 228.24%12.26B |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -8.47%19.02B | ---- | 17.22%20.78B | ---- | 7.18%17.73B | ---- | 60.36%16.54B | ---- | -0.31%10.31B |
| Refund | ---- | -14.90%-20.2B | ---- | -7.31%-17.58B | ---- | -6.42%-16.38B | ---- | 12.27%-15.39B | ---- | -30.26%-17.55B |
| Issuing shares | ---- | ---- | ---- | --346K | ---- | ---- | ---- | --51.91M | ---- | ---- |
| Interest paid - financing | ---- | -0.54%-1.12B | ---- | -110.84%-1.11B | ---- | -68.61%-526.9M | ---- | ---312.5M | ---- | ---- |
| Dividends paid - financing | ---- | 13.15%-1.26B | ---- | 68.18%-1.45B | ---- | 0.02%-4.56B | ---- | -146.67%-4.57B | ---- | -22.24%-1.85B |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---16.8M | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---11.93M | ---- | ---- | ---- | ---- | ---- | 137.52%14.67M |
| Other items of the financing business | 87.95%2.19B | ---- | -46.22%1.16B | ---- | 2,077.22%2.16B | ---- | 101.88%99.38M | 69.38%-981.29M | 9.09%-5.29B | -2,895.61%-3.2B |
| Net cash from financing operations | 87.95%2.19B | -672.32%-3.56B | -46.22%1.16B | 116.52%622.28M | 2,077.22%2.16B | 19.26%-3.77B | 101.88%99.38M | 62.00%-4.67B | 9.09%-5.29B | -151.83%-12.28B |
| Effect of rate | ---- | -197.27%-882.04M | ---- | 2.87%-296.71M | ---- | -351.25%-305.49M | ---- | -62.52%121.59M | ---- | 517.27%324.42M |
| Net Cash | -1,778.64%-780.57M | 129.81%688.04M | 97.88%-41.55M | -255.29%-2.31B | -248.83%-1.96B | 226.18%1.49B | 176.68%1.31B | -9,306.63%-1.18B | -329.45%-1.71B | 98.90%-12.52M |
| Begining period cash | -4.75%3.89B | -38.92%4.09B | -38.92%4.09B | 21.42%6.69B | 21.42%6.69B | -16.08%5.51B | -16.08%5.51B | 4.98%6.57B | 4.98%6.57B | -16.28%6.26B |
| Cash at the end | -23.06%3.11B | -4.75%3.89B | -14.57%4.05B | -38.92%4.09B | -30.61%4.74B | 21.42%6.69B | 40.63%6.83B | -16.08%5.51B | -30.69%4.85B | 4.98%6.57B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.98%6.57B |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.98%6.57B |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.